# AI for Diabetes Management: DiaSmart AI Pitch Deck
> Discover how DiaSmart AI uses artificial intelligence and digital therapeutics to revolutionize diabetes care, pathophysiology prediction, and management.

Tags: pitch-deck, diabetes-management, digital-health, artificial-intelligence, healthtech, startup-funding, medtech
## DiaSmart AI: Revolutionizing Diabetes Management
*   **Mission:** Utilizing AI to bridge the gap between diagnosis and daily management of Diabetes Mellitus.

## The Global Diabetes Crisis
*   **Statistics:** 38M+ people in the US have diabetes; 98M adults have prediabetes.
*   **Pathophysiology:** Focus on Type 2 Diabetes (insulin resistance and beta-cell dysfunction) and Type 1 (autoimmune insulin deficiency).

## Clinical Diagnosis & Symptoms
*   **Symptoms:** Polyuria, polydipsia, weight loss, and fatigue.
*   **Criteria:** HbA1c ≥ 6.5% or Fasting Plasma Glucose ≥ 126 mg/dL.

## The DiaSmart Solution
*   **Technology:** Integrates Continuous Glucose Monitoring (CGM) with AI pathophysiology simulators.
*   **Features:** Predictive complication alerts, real-time symptom checkers, and automated diet calibration.

## Management & Market Opportunity
*   **Strategy:** Combines lifestyle (MNT), oral medication (Metformin), and injectables (GLP-1/SGLT2).
*   **Market:** Total US cost burden projected at $622B by 2030; DiaSmart targets a $500M initial revenue opportunity.

## Business & Financials
*   **Model:** Freemium B2C app ($9.99/mo), B2E partnerships with payers, and anonymized data licensing.
*   **Projections:** Targeting $250M annual revenue by Year 5 through B2B adoption and international expansion.
---
This presentation was created with [Bobr AI](https://bobr.ai) — an AI presentation generator.